ACUTE INTERVENTION IN < 10 SLIDES! 1/25/2017

Slides:



Advertisements
Similar presentations
UTHSCSA Pediatric Resident Curriculum for the PICU ASTHMA IN THE PICU.
Advertisements

STATUS ASTHMATICUS Sigrid Hahn, MD Andy Jagoda, MD, FACEP Department of Emergency Medicine Mount Sinai School of Medicine New York, New York.
Cases from Aug 2014 Cases from Aug 2014 Ryan Padrez & Patrick Peebles 9/10/14.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 32 Bronchodilator Drugs and the Treatment of Asthma.
Presented by Mehrzad Bahtouee, MD Internist, Pulmonologist Assistant Professor of Internal Medicine Boushehr University of Medical sciences.
AsthmaAsthma is a condition characterized by paroxysmal narrowing of the bronchial airways due to inflammation of the bronchi and contraction of the bronchial.
British Guideline on the Management of Asthma. BTS/SIGN Guidance May 2008 (revised July 2009)
Pediatric Respiratory Emergencies Part 2 Mohammed Al Faifi, MD. Pediatric Emergency Consultant Department of Emergency Medicine King Faisal Specialist.
COPD “Trying to Expire Not Expire” Dr Esyld Watson HST Emergency Medicine.
Therapeutic Interventions in the Management of Severe Asthma Mark A. Hostetler, MD, MPH Emergency Medicine & Pediatrics The University of Chicago Pritzker.
Update on Acute Asthma Carlos Camargo, MD, DrPH Emergency Medicine, MGH Channing Laboratory, BWH Harvard Medical School
Acute severe asthma.
Drugs For Treating Asthma
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
COPD Joshua Jewell. Epidemiology 8% of all individuals 10% age >40 6 th leading cause of death worldwide th in U.S. - >120,000 Expected 3 rd 2020.
Respiratory drugs -Surag Khadka. Learning outcomes Classes of drugs MoA of the following Beta-2 agonists Anti-cholinergics Leukotriene antagonists Methylxanthines.
Medications for the Acute Management of Asthma A. Shaun Rowe, Pharm.D., BCPS.
British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.
Immunology of Asthma Immunology Unit Department of Pathology King Saud University.
Asthma Management Pathophysiology and Management University of Utah Center for Emergency Programs and The Utah Asthma Program.
CLINICAL PATHWAY FOR ADULT ASTHMA
Childhood Asthma A triad of atopic eczema, allergic rhinitis and asthma is called atopy.[53] The strongest risk factor for developing asthma is a history.
CHAT Asthma Collaborative
Case No. 12 SH, 25 years old with a history of asthma since childhood presented to the OPD clinic with complaints of worsening dyspnea and wheezing. He.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Bronchodilating Drugs Pat Woodbery, ARNP, CS Professor of Nursing.
Dr Fahad SHO ED. What to do in ER COPD Chronic obstructive pulmonary disease (COPD) is a long-term condition that causes inflammation in the lungs,
1.8 million ED visits yearly in US 100 million lost school/work days Can develop at any age 50% symptomatic by age 6.
RESPIRATORY DRUGS CHAPTER 6. ANTITUSSIVES -The cough reflex occurs when receptors in the airway send impulses to the brainstem and cause contraction of.
Asthma DR Sattam Alenezi EM consultant. Asthma is one of the most common chronic diseases in adults Affecting 300 million people worldwide.
Update Presented by: Katy Zahner BSN, RN, CCRN Georgetown University Nurse Educator Student.
Bronchodilators and Other Respiratory Agents
Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD).
Drugs Used to Treat Asthma Dr. Najlaa Saadi Ismael Department of Pharmacology Mosul college of Medicine University of Mosul.
СOPD Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that.
Helmi Lubis, dr, SpAK Ridwan M. Daulay, dr, SpAK Wisman Dalimunthe, dr, SpA Rini S. Daulay, dr, M.Ked(Ped), SpA.
β2 Agonists Albuterol and other inhaled short-acting selective β2 agonists are indicated for treatment of intermittent episodes of bronchospasm and are.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Acute asthma exacerbations in children: Outpatient management ] Dr. hala alrifaee.
Asthma. Asthma: chronic inflammation of the bronchial tubes that causes swelling and constriction.
Management Of Asthma With Acute Exacerbation In Pediatric Patients Speaker : Dr. Meng-Shu Wu.
Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &
Dyspnea in the ED I – Asthma and COPD
Pharmacology of Anti- Asthmatic Medications
Children's Asthma Care Core Measures
Update on Critical and Near-Fatal Asthma
Eileen G. Holland, Pharm.D., BCPS Associate Professor
Asthma in the child Dr A Rahman GPST3.
Management of Chronic Airflow Obstruction
Management of Severe Asthma and COPD
Respiratory disorders
Immunology Unit Department of Pathology King Saud University
Asthma Case Study – Module 9.
Chapter 9 Respiratory Drugs.
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
Drugs affecting the respiratory system
Respiratory System Diseases and Management Part IV
COPD By Alaina Darby.
APPROACH TO A PATIENT WITH ACUTE SEVERE ASTHMA
Systemic Procaterol (Meptin) as a CONTROLLER for Asthma
Systemic Procaterol (Meptin) as a CONTROLLER for Asthma
Asthma.
COPD Exacerbations UCI Internal Medicine Mini-Lecture
Respiratory disorders
COPD Exacerbation (1) C.L.I.P.S.
PHARMACY TECHNICIAN CHAPTER TWENTY FIVE.
Drugs Affecting the Respiratory System
Immunology Unit Department of Pathology King Saud University
Immunology Unit Department of Pathology King Saud University
DP2 Antagonism, Oral Therapy for Moderate to Severe Asthma
Presentation transcript:

ACUTE INTERVENTION IN < 10 SLIDES! 1/25/2017 Pediatric Asthma ACUTE INTERVENTION IN < 10 SLIDES! 1/25/2017

Pathogenesis Inflammation Obstruction Hyper-responsivness - Origins of asthma primarily occur early in life. - The expression of asthma is a complex, interactive process that depends on the interplay between two major factors—host factors (particularly genetics) and environmental exposures that occur at a crucial time in the development of the immune system Pathogenesis PARTIALLY REVERSIBLE

Bronchoconstriction (bronchial smooth muscle contractions) Airway Edema Airway hyper-responsiveness (exaggerated bronchoconstriction) Airway remodeling Pathogenesis

Ipratropium  blocks acetylcholine receptors  bronchodilation Albuterol  stimulates beta-2 adrenergic receptors  relaxing airway smooth muscle

https://www.colorado.gov/pacific/sites/default/files/HTW_Asthma-Management-for-Children-and-Adults_03-21-2013.pdf

Asthma Ex: ER Triage O2 for <90% Ipratropium and albuterol x 3 <20 kg: 2.5 mg >20 kg: 5 mg Dexamethasone 0.6 mg/kg x 2 days Prednisone 2 mg/kg in 2 doses x 3-5 days Continuous neb and recheck in 1 hour <20 kg : 7.5 mg/hr >20 kg: 10 mg/hr Admission, IV Mag, noninvasive ventilation, ABG, CXR , transfer Based on Pediatric Assessment Severity Score: RR, O2, Auscultation, Retractions, Dyspnea Show on EPIC, respiratory flow sheet Oral = IV steroids for bioavailability Asthma Ex: ER Triage

Discharge criteria PAS score < 7 SpO2 > 90% on room air Continue BD q4 hr x 3 days, f/u, or oral steroids complete Rx ICS if h/o prior ED visit Asthma Education/Action Plan Discharge criteria

https://www.nhlbi.nih.gov/files/docs/guidelines/03_sec2_def.pdf Children’s Hospital Colorado https://www.colorado.gov/pacific/sites/default/files/HTW_Asthma-Management-for-Children-and-Adults_03-21-2013.pdf References